|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Use of a symptom index, CA125, and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gyneeol Oneol2010，116，3： | 1 |
| 2 | Diagnosis and recomment of esophageal perforation and rupture显示文摘 | Bladergrone MR Lowe JE Postlethwait RW | 1986 | Ann Thorac Surg1986，42，： | 1 |
| 3 | Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes显示文摘 | Bruchas MR Macey TA Lowe JD | 2006 | J Biol Chem2006，281，18： | 1 |
| 4 | Use of a Symptom Index,CA125 and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | | 0，，： | 1 |
| 5 | Use of a Symptom Index,CA125, and HE 4 to predict ovarian cancer 显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gynecol Oncol2010，116，3： | 1 |
| 6 | Use of a symptom index, CA125, and HE4 to predict ovarian cancer 显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gynecol Oncol2010，116，： | 1 |
| 7 | Combining a symptoms index with CA125 to improve detection of ovarian cancer 显示文摘 | Andersen MR Goff BA Low e KA | 2008 | Cancer2008，113，： | 1 |
| 8 | Use of a symptom index,CA125,and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gynecol Oncol2010，116，3： | 1 |
| 9 | Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype 显示文摘 | Lowe H MeMahon DJ Rubin MR | 2007 | J Clin Endocrinol Metab2007，，： | 1 |
| 10 | Functional magnetic resonance neuroimaging of drug dependence:naloxone-precipitated morphine withdrawal显示文摘 | Lowe AS Williams SC Symms MR | 2002 | Neuroimage2002，17，2： | 1 |
| 11 | Use of a Symp- tom Index, CA125, and HE4 to predict ovarian cancer显示文摘 | Andersen MR Golf BA Lowe KA | 2010 | Gynecol Oncol2010，116，3： | 1 |
| 12 | Diagnosis and recommended management of esophageal perforation and rupture显示文摘 | Bladergroen MR Lowe JE Postlethwait RW | 1986 | Ann Thorac Surg1986，42，3： | 1 |
| 13 | Use of a symptomindex,CA125,and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | GynecolOncol2010，116，3： | 1 |
| 14 | Normocalcemic primary hyperparathyroidism:further characterization of a new clinical phenotype显示文摘 | Lowe H McMahon DJ Rubin MR | 2007 | Clin Endocrinol Metab2007，92，： | 1 |
| 15 | Use of a symp- tom index,CA125 and HE4 to predict ovarian cancer显示文摘 | Andersen MR Golf BA Lowe KA | 2010 | GynecoI Oncol2010，116，9： | 1 |
| 16 | The role of third generation β-blocking agents in chronic heart failure 显示文摘 | Roden RL Lowes BD | 1998 | Clin Cardiol1998，21，121： | 1 |
| 17 | Involvement indecision-making about treatment and ovarian cancer sur-vivor quality of life显示文摘 | Andersen MR Sweet E Lowe KA | 2012 | Gynecol Oncol2012，124，3： | 1 |
| 18 | Use of a Symptom Index,CA125,and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gynecol Oncol2010，116，3： | 1 |
| 19 | Normocalcemic primary hyperparathyroidism:further characteri-zation of a new clinical phenotype显示文摘 | Lowe H McMahon DJ Rubin MR Bilezikian JP Silverberg SJ | | 0，，： | 1 |
| 20 | Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer显示文摘 | Andersen MR Goff BA Lowe KA | 2010 | Gynecol Oncol2010，116，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员